Most Viewed Articles from NEJM

Item request has been placed!

Item request cannot be made.

Processing Request

Beyond the First Dose — Covid-19 Vaccine Follow-through and Continued Protective Measures

Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia

Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19

Vaccine Breakthrough Infections with SARS-CoV-2 Variants

Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons

SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia

Pathologic Antibodies to Platelet Factor 4 after ChAdOx1 nCoV-19 Vaccination

Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination — Response from the Manufacturer

BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting

Pages